Navigation Links
Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
Date:3/26/2009

SAN DIEGO, March 26 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported highlights and financial results for its fourth quarter and fiscal year ended December 31, 2008, and other important recent developments and outlook for 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

Recent Developments and 2009 Outlook

Cardium's business is focused on the acquisition and strategic development of product opportunities or businesses having the potential to address significant unmet medical needs, and definable pathways to commercialization, partnering or other monetization. As our product opportunities and businesses are advanced and corresponding valuations established, we intend to consider various corporate development transactions designed to place our product candidates into larger organizations or with partners having existing commercialization, sales and marketing resources, and a need for innovative products. Such transactions could involve the sale, partnering or other monetization of particular product opportunities or businesses. In November 2008, Cardium reported that it was focusing principal near-term efforts on its InnerCool Therapies and Tissue Repair subsidiaries - both of which we believe are nearing completion of their strategic development programs initiated in 2006.

InnerCool Therapies completed its high-performance endovascular-based cooling system, RapidBlue(TM), and the system was cleared by the FDA in late 2008. InnerCool also developed a new class of targeted organ-specific cooling applications, including its UroCool(TM) pelvic cooling catheter system, which is designed to induce localized cooling during surgery for prostate cancer.
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Cardiums Exchange Listing Compliance Plan Accepted by NYSE Alternext US
2. Cardiums InnerCool Reports on Expanding Use of Therapeutic Hypothermia
3. Cardiums InnerCool Announces Launch of New Enhanced Website
4. Cardium Reports on Exchange Listing With NYSE Alternext US
5. Cardium Reports on New York Citys Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients
6. Cardium Announces Investor Presentation and Corporate Update Webcast
7. Cardium Completes $6.0 Million Financing
8. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
9. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
10. Cardium Reports on Recent Highlights and Financial Results
11. An international first at the CHUM - Promising treatment in regeneration of the myocardium through the use of stem cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Sunday, more than 900 runners and walkers from La...sh line at the Rock ‘n’ Roll Las Vegas... $3.2 million for the Crohn,s & Colitis Founda...eam Challenge (www.ccteamchallenge). As the offici...esearch, education, and support initiatives to ben...
(Date:12/2/2009)...ec. 2 Pro-abortion acti... 2 in their campaign against the U.S. House bill,s... United for Life President and CEO Charmaine Yoest...on lobby,s effort to expand taxpayer funding of ab...are, the feminist groups and the abortion lobby ac...
(Date:12/2/2009).../PRNewswire/ -- The Universities of Sassari and ...team of doctors from the United States, announced ...y confirming that Pecorino cheese contains high am...6 polyunsaturated fatty acid naturally found in ce...rties for humans. ,, The study, conducted in ...
(Date:12/2/2009)...in tobacco, but risk is unclear , , WEDN...ovides evidence that the average cigarette is craw...piratory disease. , But as one spokesman for a ...w study aren,t sure what, if any, hazard the germs...crobes surround us every day of our lives. , S...
(Date:12/2/2009)...e unlikely heroes in the battle against drug abuse...ready used to study dozens of human disease could...uit flies can be used as a simpler and more conven...ine and other drugs of abuse on the brain. Their s..., a new monthly journal. , Andrew Ewing and col...
Breaking Medicine News(10 mins):Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 3Health News:Smokers Inhaling Germs With Each Cigarette 2
...e millions of women,who,ve been prescribed Hormone... and Provera) to treat the symptoms of menopause? ...king HRT drugs -- specifically the,heightened risk...s. Are you one of these women? You might not be si...
...t the familys history of cancer significantly impa...ng and testing for those at moderate risk of devel...y study presented today at the American Society fo...ting for the genes that put women at risk for brea...
...one-stop access to scenic attractions, COLUMBIA, ... who travel to Costa Rica for care now have a conv... parks, coffee farms, biological reserves,and othe...care Inc., has affiliated with Tropical Expedition...
...thy Coffee USA,Inc., the marketing arm of Healthy ...ounced today that Wendell Tyler of the San Francis... the Miami Dolphins, has joined the,Founders Club ... Mr. Tyler,s joining Healthy Coffee USA is histori...
...ve the health of patients with rheumatoid arthriti...cal universit Karolinska Institutet. The diet has ...rdiovascular disease. , Rheumatoid arthritis is a...searchers suspect that the disturbed balance of bl...
..., increased levels of uric acid in the blood may b...g before any significant change in urine albumin l... in the May 2008 issue of the Clinical Journal of ...in patients with diabetes. "Thus we have the hope ...
Other Medicine News:Health News:Alert to Women: What Your Doctor Prescribed for Hormone Replacement May Be Killing You and Your Rights Are About to Be Taken Away 2Health News:Family communication impacts attitude about genetic counseling/testing for breast cancer 2Health News:Companion Global Dental Clients Have New Reason to Smile in Costa Rica 2Health News:Wendell Tyler, of San Francisco 49ers Super Bowl XIX Fame, Joins Healthy Coffee USA's Founders Club 2Health News:Wendell Tyler, of San Francisco 49ers Super Bowl XIX Fame, Joins Healthy Coffee USA's Founders Club 3Health News:Uric acid may provide early clues to diabetic kidney disease 2
(Date:12/1/2009)...., Dec. 1 Merck & Co., Inc. to...ration (FDA) has approved ZEGERID OTC(TM) (omepraz...r over-the-counter treatment of frequent heartburn...y Schering-Plough HealthCare Products, Inc., the c...c. Schering-Plough and Merck merged on November 3,...
(Date:12/1/2009)... Reportlinker.com announces that a ...alogue: ,, Latin American Pharmaceutical Mark...lysis, forecasts and growth opportunities ,, ...can-Pharmaceutical-Market-Outlook-To-2014-Policy-e...portunities.html ,, The $28.8bn Latin Americ...
(Date:12/1/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, The Future of Oncology Therapeutics -...g, Product Pipeline and Deals Analysis ,, htt...cology-Therapeutics---Market-Forecasts-to-2015-Com...nalysis.html ,, Summary ,, The author has...
Breaking Medicine Technology:FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 2Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 5Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 6Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 8Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3New Anti Clotting Drug Beats Plavix 55655 1New Anti Clotting Drug Beats Plavix 55655 2New Anti Clotting Drug Beats Plavix 55655 3New Anti Clotting Drug Beats Plavix 55655 4Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 1Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 2Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 3Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 4Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 5Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 6Get Ready for Ragweed 55647 1Get Ready for Ragweed 55647 2
... MATEO, Calif., Sept. 4 BioForm Medical,Inc. (Nas...ical study of,Polidocanol, conducted in Germany by...SLER & Co. GmbH (Kreussler), successfully met the ...DA as part of a New Drug Application,(NDA) process...(Efficacy and safety of,Aethoxysklerol compared to...
...otal Study Seeks to Enroll 750 Women at More Than ... QuatRx Pharmaceuticals, a,privately-held biopharm...rcialization of compounds to treat endocrine, meta...d that it has initiated a second,Phase 3 clinical ...any,s,estrogen-free oral therapy in development fo...
Other Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: